PLX9486
Showing 1 - 4 of 4
Gastrointestinal Stromal Tumors Trial in United States (PLX9486, Pexidartinib, Sunitinib)
Completed
- Gastrointestinal Stromal Tumors
- PLX9486
- +2 more
-
Miami, Florida
- +5 more
Apr 30, 2021
SSM, Mastocytosis, Indolent, Mastocytosis, Systemic Trial in United States (CGT9486 Tablets, Placebo Tablets)
Recruiting
- SSM
- +3 more
- CGT9486 Tablets
- Placebo Tablets
-
Clearwater, Florida
- +5 more
Apr 14, 2022
Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in
Recruiting
- Advanced Systemic Mastocytosis (AdvSM)
- +3 more
- CGT9486 tablets
-
Duarte, California
- +10 more
Jul 8, 2022
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer Trial in United States (CGT9486 plus sunitinib, CGT9486, Sunitinib)
Recruiting
- Advanced Gastrointestinal Stromal Tumors
- Metastatic Cancer
- CGT9486 plus sunitinib
- +2 more
-
Duarte, California
- +11 more
Aug 10, 2022